These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4589453)

  • 1. Antibody-dependent killing of Cryptococcus neopormans by human peripheral blood mononuclear cells.
    Diamond RD
    Nature; 1974 Jan; 247(5437):148-50. PubMed ID: 4589453
    [No Abstract]   [Full Text] [Related]  

  • 2. Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans.
    Diamond RD; Allison AC
    Infect Immun; 1976 Sep; 14(3):716-20. PubMed ID: 786891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: Mononuclear cells killing Cryptococcus.
    Sethi KK
    Nature; 1974 Dec; 252(5485):758. PubMed ID: 4612379
    [No Abstract]   [Full Text] [Related]  

  • 4. C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes.
    Bobak DA; Washburn RG; Frank MM
    J Immunol; 1988 Jul; 141(2):592-7. PubMed ID: 3290342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines.
    Levitz SM; Farrell TP
    Infect Immun; 1990 May; 58(5):1201-9. PubMed ID: 2182538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes.
    Davies SF; Clifford DP; Hoidal JR; Repine JE
    J Infect Dis; 1982 Jun; 145(6):870-4. PubMed ID: 7045251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
    Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
    Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro.
    Diamond RD; Root RK; Bennett JE
    J Infect Dis; 1972 Apr; 125(4):367-76. PubMed ID: 4553080
    [No Abstract]   [Full Text] [Related]  

  • 9. Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans.
    Griffin FM
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3853-7. PubMed ID: 7022456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.
    Diamond RD; May JE; Kane MA; Frank MM; Bennett JE
    J Immunol; 1974 Jun; 112(6):2260-70. PubMed ID: 4596700
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypersensitivity pneumonitis with antibodies to Cryptococcus neoformans.
    Miyagawa T; Ochi T; Takahashi H
    Clin Allergy; 1978 Sep; 8(5):501-9. PubMed ID: 152171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes.
    Miller MF; Mitchell TG
    Infect Immun; 1991 Jan; 59(1):24-8. PubMed ID: 1987038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of specific antibody to Cryptococcus neoformans by hybridomas in vitro.
    Hall NK; Blackstock R
    Sabouraudia; 1981 Jun; 19(2):157-60. PubMed ID: 7020113
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry.
    Chaka W; Scharringa J; Verheul AF; Verhoef J; Van Strijp AG; Hoepelman IM
    Clin Diagn Lab Immunol; 1995 Nov; 2(6):753-9. PubMed ID: 8574842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.
    Rachini A; Pietrella D; Lupo P; Torosantucci A; Chiani P; Bromuro C; Proietti C; Bistoni F; Cassone A; Vecchiarelli A
    Infect Immun; 2007 Nov; 75(11):5085-94. PubMed ID: 17606600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killing of Cryptococcus neoformans by rat alveolar macrophages.
    Bolaños B; Mitchell TG
    J Med Vet Mycol; 1989; 27(4):219-28. PubMed ID: 2677299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungicidal components of mammalian granulocytes active against Cryptococcus neoformans.
    Lehrer RI; Ladra KM
    J Infect Dis; 1977 Jul; 136(1):96-9. PubMed ID: 328789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
    Kozel TR; Gotschlich EC
    J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
    Bolaños B; Mitchell TG
    J Med Vet Mycol; 1989; 27(4):203-17. PubMed ID: 2677298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.